Hacker News Reader

You've diagnosed the issue then recommended leaches and bleeding.

'Market mechanisms' already exist - no company is precluded from doing research. We can discuss the deficit in research investment that short termist 'market mechanisms' have led to in contemporary corporations, but its absurd to claim that the market can or should replace academic research.

It's pretty clear that in practice the 'publish or perish' academic culture fostered by the financialisation of the university, the rise of the adjunct and the death of tenure have contributed heavily to the falsification of research. In practice encouraging replication, self directed research and significantly more 'pure' 'blue sky' research than governments and universities are inclined to do, would significantly alleviate this problem.

Academia needs far less exposure to 'market mechanisms'. They're perverse incentives for good science.

To say there's a deficit in research spending pre-supposes there's a correct absolute level of resource allocation that is easily discoverable. But the reason we need markets in the first place is that governments aren't able to discover the right levels of resource allocation on their own. That's why the USSR ended up with lots of steel foundries but no software companies, nor even any competitor to the internet.

If anything research is clearly over-funded right now, especially in some fields like medical research. That's why so many scientists turn to fraud in desperation. There just aren't enough genuine discoveries to go round.

> encouraging replication, self directed research and significantly more 'pure' 'blue sky' research

Replication is the opposite of self directed blue sky research, so how do you suggest it be encouraged whilst simultaneously reducing the power of the money givers even further? BTW, many bogus papers will replicate whilst still being wrong. Replicability is not a synonym for good science.

Really, this is a very common claim that needs to go away. The solution to fraud and incompetence is not to give incompetent fraudsters even more freedom and money.

> But the reason we need markets in the first place is that governments aren't able to discover the right levels of resource allocation on their own.

Markets don't discover "the right" (i.e. social welfare maximizing) resource allocation, they discover, under ideal conditions, a pareto-optimal allocation. This is a very weak condition: "Jeff Bezos owns everything" is pareto-optimal. You need redistribution if you want to turn that into a socially optimal one.

In realistic conditions, they don't even do that: market mechanisms will reliably underinvest in things with positive externalities, and the larger the externality the greater the degree of misallocation. The positive externalities of research are enormous compared to the value captured by the researchers.

No market system anywhere ends up with one person owning everything. That is the standard under non-market systems, though.

> The positive externalities of research

... are only relevant if it's actually research, and not something that looks a lot like research without actually being so.

In reality, it is in non-market economies that you have a few owning everything: North Korea (the Kim family), USSR (the party), etc.

Maybe it should become best practice to publish honeypots. Anyone who claims to reproduce these papers or cites thsm gets autolisted for fraud.

> Academic science is excluded from market mechanisms by legal fiat.

This to me just seems untrue. What is your basis for this claim? There is plenty of research privately funded by corporations, some of which is very influential. Often this work is published by university researchers. Ask any university researcher about the numerous compliance courses we all have to take about funding and conflict of interest.

It is true that the biggest funders (NSF, NIH) are not market-focused, but for good reason. The market does not prioritize the public good. I know first hand -- my son has a rare disease (1 out of 20,000 people). There are many drug companies putting vast resources into drug development in the hopes of a huge payoff. In reality this benefits a small number of people (I remain grateful for how improvements have helped us). I'm grateful our major scientific funding bodies are not swayed entirely by market influences because it would lead to us focusing on a narrow set of scientific problems which would ultimately limit the way it helps the public good.

Im any event, I work in biomedical research. I think your diagnosis (incentives, process) is correct, but the way you discuss the attitudes and motives of researchers is wrong-headed.

You say:

> Their reputation is tanking but they just don't seem to care and why should they? They'll get grants from the NIH anyway because they're all as bad as each other, and nobody in politics is talking about a total defunding of the sector yet.

You're talking about hundreds of thousands of researchers as if they're all psychotic citation fanatics with no care for truth. That is not reality. I think the kind of psychotic, data-manipulating researcher who would put people's health and lives at risk for citations -- or fabricate data sets out of thin air -- are vanishingly small. We can point to a handful of them -- the author of this paper, and the Daniel Ariely's and Francesca Gino's of the world -- but there are tens of thousands of people in every field working on research in good faith, with utmost care. The vast, vast majority never have any scandal, never get caught up in data manipulation, and so on.

No field I know of out-right tolerates fraud (and I follow all the retraction stories fairly closely). I think the closest we get to "toleration" is researchers dealing with scientific problems who more or less say "we're not going to publicly flay you but behind your back we're all going to know what you did and your future is limited when it comes to big grants, prestigious invitations, and so on." People who are credibly accused of fraud become pariahs and often targets of scorn not only within the research community but in the press and wider community.

The most serious issue IMO is not outright but poor norms around scientific practice, leading to p-hacking, harking, and other "forking paths" problems. Calling that type of behavior "fraudulent" is perhaps justifiable under some ways of thinking, but I think the word fraud mischaracterizes what is going on. There are, in fact, many serious efforts to root out this type of behavior and put in transparency rules to open up research to scrutiny, including among funders like the NIH.

> What is your basis for this claim?

Well you answered your own question: It is true that the biggest funders (NSF, NIH) are not market-focused. A lot of research is funded by taxes. That's an exclusion from market mechanisms. They don't have to convince the actual consumers of the research to buy it, we are all collectively forced to buy it by law.

> No field I know of out-right tolerates fraud

I know quite a few such fields, so we might have a different definition of "tolerate". After all this story contains the following paragraph:

“It’s unfortunate that it has taken 2 years to make the decision to retract,” says Donna Wilcock, an Indiana University neuroscientist and editor of the journal Alzheimer’s & Dementia. “The evidence of manipulation was overwhelming.”

We're talking about a retraction here, which is the weakest response possible. So ... it took two years of "investigation" to do nearly nothing, after other people did all the investigative work for free, and one of the authors continues to be employed with no consequences whatsoever even though his co-author admitted the figures were tampered with. I'd argue this is what institutional tolerance of fraud looks like.

There are no "consumers" who "buy" basic research.

You're talking about fundamental research into basic scientific questions as if it were the same as potato-chip manufacturing.

The "consumer" who "buys" research in a commercial setting is usually the executive who is funding the department. In that context stuff like P-hacking, HARKing etc doesn't happen much because at some point your bosses boss is going to read your internal paper and notice that your claimed discovery has nothing to do with what you were originally asked to investigate. In academia that doesn't matter, it still counts as a discovery because nobody is really checking your pre-registrations. In corporate research it'll either be checked by the people paying your salary, or at a larger scale, it'll be checked by a regulator who is forcing you to pre-register your clinical trials.

There's no "consumer" who "buys" research into whether protons decay. That's basic research that will only occur if funded by national agencies that are not motivated by return on investment.

As for commercial research, similar problems of fraud exist as in academic research. Instead of prestige, the motivations are things like bonuses and promotions.

Academics actually care a great deal about fraud, funding agencies hate fraud and punish it, journals hate fraud - everyone dislikes it. Competing labs have every incentive to catch fraud conducted by their rivals. The idea that academia is rife with fraud and that nobody cares is just not true.

There will always be a certain level of fraud not just in research, but in every economic sector, every intellectual pursuit, and every sport, commercial or not. There's no system that will perfectly eliminate it, but because of its empiricism and openness, science is fairly good at correcting itself over time.

Physics gets large amounts of commercial investment. Quantum computers have been invested in heavily by the private sector for years. The defense world invests in laser research, etc. Plenty of examples out there. You can always find a topic you personally feel is super important even though it has no practical applications today, but such arguments are unfalsifiable. I can just as easily argue [more] proton decay research doesn't matter [yet] and you can't prove I'm wrong, so it's not worth going there.

The same problems exist but not on the same scale. If your employer discovers you committed fraud to get a promotion you will certainly be fired and quite probably be taken to court by their legal department. If the fraud is at the level of the company they risk destruction and imprisonment by the government. It's not like in academia where they'll sit on it for years and then, maybe, request a little notice to be put on the paper's web page - all without the government even noticing let alone caring. The huge difference in consequences yields different risk/reward ratios and that's reflected in how often these problems are found.

> Academics actually care a great deal about fraud, funding agencies hate fraud and punish it, journals hate fraud - everyone dislikes it.

Do they? How is the co-author of this paper still employed if funding agencies punish it? Where are the university funded research-police departments? Why do we keep hearing cases like this Alzheimer's one and why are there never any announcements by Vice Chancellors about doubling investment into fraud investigations as a consequence? Why is a research audit not something that these fraudsters fear? How is it the case that publishers discover after the fact that dozens of their journals have been completely compromised by paper mills, instead of it being discovered via some more active process before publication occurs?

> science is fairly good at correcting itself over time

Absolutely not. If science was good at self correcting it wouldn't take nearly two decades for someone to notice that a widely cited paper was forged, and the people who notice these things wouldn't need to be anonymous. But they do. Look at the Gino case. She launched a massively well funded lawsuit against the people claiming she engaged in fraud. That's the exact opposite of self correction.

> Physics gets large amounts of commercial investment.

Almost all funding for basic research, including for physics, comes from governments. There are a few niche areas of basic research, like quantum computing, that also attract commercial investment, and there is plenty of applied research, but governments are almost the only game in town for basic research.

I think fraud is actually a much larger problem in commercial research, because the incentives to cheat are much stronger. There's real money at play. Theranos was a massive fraud. There's plenty of fraud and misconduct in the pharma industry. And when it comes to academia, the fields that have the most commercial potential (like biomedical research) have the worst problems with fraud.

> How is the co-author of this paper still employed if funding agencies punish it?

Is the co-author guilty of fraud?

> Where are the university funded research-police departments?

It's the funding agencies, the journals and other academics that are most involved in finding fraud.

> Why do we keep hearing cases like this Alzheimer's one

Because there's a huge volume of research, and some small percentage of it will be fraudulent.

> why are there never any announcements by Vice Chancellors about doubling investment into fraud investigations as a consequence?

That might be a bad allocation of resources. If fraud is a rare phenomenon and isn't severely impacting a field, then the current level of investigations might be sufficient. Add to that the fact that the way most of these frauds are uncovered is by competing researchers.

> Academic science is excluded from market mechanisms by legal fiat...

And a world class propaganda game. Go onto mainstream social media, pick a science fan at random out of the crowd and pick an argument with them about science. The average fan would have you believe that science is just short of perfect.

In a sense it's hard to blame these people, considering what two years of the media machine's full court press of pro-science culture war propaganda during a global pandemic does to a mind of average intelligence.

I mean, I suppose "winning" is important folks, but is losing your soul in the process worth it?